CINF
51
4
SRE
66
3
MAS
56
5
TEL
66
6
BIIB
28
2
SBUX
39
3
FITB
60
2
KMX
64
6
CSX
57
6
STX
56
4
GOOG
53
-12
AIV
70
2
COST
63
5
DE
56
10
FOXA
59
4
DOW
34
4
PSA
56
5
AA
60
9
BRK.B
42
2
UNP
45
6
CINF
51
4
SRE
66
3
MAS
56
5
TEL
66
6
BIIB
28
2
SBUX
39
3
FITB
60
2
KMX
64
6
CSX
57
6
STX
56
4
GOOG
53
-12
AIV
70
2
COST
63
5
DE
56
10
FOXA
59
4
DOW
34
4
PSA
56
5
AA
60
9
BRK.B
42
2
UNP
45
6
Financhill
Back

Sanofi SA Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

SNY
Sanofi SA

Last Price:
48.27
Seasonality Move:
-0.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Sanofi SA Price Quote

$48.27
+0.29 (+0.6%)
(Updated: November 22, 2024 at 5:55 PM ET)

Sanofi SA Key Stats

Sell
30
Sanofi SA (SNY) is a Sell
Day range:
$47.56 - $48.04
52-week range:
$45.22 - $58.97
Dividend yield:
8.21%
P/E ratio:
20.61
P/S ratio:
2.26
P/B ratio:
1.54%
Volume:
1.4M
Avg. volume:
2.1M
1-year change:
3.07%
Market cap:
$120.3B
Revenue:
$50.3B
EPS:
$1.97

How Much Does Sanofi SA Make?

  • How Much Are Sanofi SA's Sales Annually?
    SNY Revenues are $50.3B
  • How Much Profit Does Sanofi SA's Make A Year?
    SNY net income is $5.8B

Is Sanofi SA Growing As A Company?

  • What Is Sanofi SA's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Sanofi SA's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.13%

Sanofi SA Stock Price Performance

  • Did Sanofi SA Stock Go Up Last Month?
    Sanofi SA share price went down by -10.59% last month
  • Did SNY's Share Price Rise Over The Last Year?
    SNY share price rose by 3.07% over the past 1 year

What Is Sanofi SA 52-Week High & Low?

  • What Is Sanofi SA’s 52-Week High Share Price?
    Sanofi SA has traded as high as $58.97 over the past 52 weeks
  • What Is Sanofi SA’s 52-Week Low Share Price?
    Sanofi SA has traded as low as $45.22 over the past 52 weeks

Sanofi SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sanofi SA?

Data Unavailable

Is Sanofi SA Cash Flow Positive?

Data Unavailable

Sanofi SA Return On Invested Capital

Data Unavailable

Sanofi SA Earnings Date & Stock Price

  • What Is Sanofi SA's Stock Price Today?
    A single share of SNY can be purchased today for 47.98
  • What Is Sanofi SA’s Stock Symbol?
    Sanofi SA trades on the nasdaq under the ticker symbol: SNY
  • When Is Sanofi SA’s Next Earnings Date?
    The next quarterly earnings date for Sanofi SA is scheduled on January 31, 2025
  • When Is SNY's next ex-dividend date?
    Sanofi SA's next ex-dividend date is May 9, 2024
  • How To Buy Sanofi SA Stock?
    You can buy Sanofi SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Sanofi SA Competitors

  • Who Are Sanofi SA's Competitors?
    Below is a list of companies who compete with Sanofi SA or are related in some way:
    • AstraZeneca PLC (AZN)
    • GSK PLC (GSK)
    • Eli Lilly and Co (LLY)
    • Novavax Inc (NVAX)
    • Regeneron Pharmaceuticals Inc (REGN)

Sanofi SA Dividend Yield

  • What Is SNY Dividend Yield?
    Sanofi SA’s dividend yield currently is 8.21%
  • What Is Sanofi SA’s Payout Ratio?
    Sanofi SA’s payout ratio is 102.79%
  • When Did Sanofi SA Last Pay A Dividend?
    The latest dividend pay date is November 23, 2024
  • What Is Sanofi SA’s Dividend Per Share?
    Sanofi SA pays a dividend of $0.00 per share

Sanofi SA Analyst Estimates

YoY Growth Past Surprise
EPS: 13.07% 11.72%
Revenue: 12.62% 6.49%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 63.49
Upside from Last Price: 32.33%

Major Shareholders

  • How many SNY shares are owned by institutional investors?
    341.5M SNY shares are owned by institutional investors
  • How many SNY shares are owned by insiders?
    0 SNY shares are owned by insiders